Veeco Reports Fourth Quarter and Fiscal Year 2024 Financial Results

Fourth Quarter 2024 Highlights:

Revenue of $182.1 million, compared with $173.9 million in the same period last year
GAAP net income of $15.0 million, or $0.26 per diluted share, compared with $21.6 million, or $0.37 per diluted share in the same period last year
Non-GAAP net income of $24.2 million, or $0.41 per diluted share, compared with $29.8 million, or $0.51 per diluted share in the same period last year

Fiscal Year 2024 Highlights:

Revenue of $717.3 million, compared with $666.4 million in the same period last year
GAAP net income of $73.7 million, or $1.23 per diluted share, compared with GAAP net loss of $30.4 million or $0.56 loss per diluted share in the same period last year
Non-GAAP net income of $104.3 million, or $1.74 per diluted share, compared with $98.3 million, or $1.69 per diluted share in the same period last year

PLAINVIEW, N.Y., Feb. 12, 2025 (GLOBE NEWSWIRE) — Veeco Instruments Inc. (Nasdaq: VECO) today announced financial results for its fourth quarter and fiscal year ended December 31, 2024. Results are reported in accordance with U.S. generally accepted accounting principles (“GAAP”) and are also reported adjusting for certain items (“Non-GAAP”). A reconciliation between GAAP and Non-GAAP operating results is provided at the end of this press release.


U.S. Dollars in millions, except per share data

	4th Quarter				Full Year
GAAP Results	Q4 ’24		Q4 ’23		2024		2023
Revenue	$	182.1	$	173.9	$	717.3	$	666.4
Net income (loss)	$	15.0	$	21.6	$	73.7	$	(30.4	)
Diluted earnings (loss) per share	$	0.26	$	0.37	$	1.23	$	(0.56	)

	4th Quarter				Full Year
Non-GAAP Results	Q4 ’24		Q4 ’23		2024		2023
Operating income	$	27.4	$	32.1	$	116.1	$	109.6
Net income	$	24.2	$	29.8	$	104.3	$	98.3
Diluted earnings per share	$	0.41	$	0.51	$	1.74	$	1.69

“Veeco had a successful year in 2024, highlighted by our Semiconductor business outperforming WFE growth for the 4^th consecutive year,” commented Bill Miller, Ph.D., Veeco’s Chief Executive Officer. “We achieved several strategic milestones, grew the top-line and delivered solid profitability, all while continuing to allocate capital toward our largest growth opportunities. Looking ahead, our solutions in Laser Annealing, Ion Beam Deposition, and Advanced Packaging are well-positioned to take advantage of growth in leading edge investment in the coming years.”

Guidance and Outlook

The following guidance is provided for Veeco’s first quarter 2025:

Revenue is expected in the range of $155 million to $175 million
GAAP diluted earnings per share are expected in the range of $0.11 to $0.22
Non-GAAP diluted earnings per share are expected in the range of $0.26 to $0.36

Conference Call Information

A conference call reviewing these results has been scheduled for today, February 12, 2025 starting at 5:00pm ET. To join the call, dial 1-877-407-8029 (toll-free) or 1-201-689-8029. Participants may also access a live webcast of the call by visiting the investor relations section of Veeco’s website at ir.veeco.com. A replay of the webcast will be made available on the Veeco website that evening. We will post an accompanying slide presentation to our website prior to the beginning of the call.

About Veeco

Veeco (NASDAQ: VECO) is an innovative manufacturer of semiconductor process equipment. Our laser annealing, ion beam, chemical vapor deposition (CVD), metal organic chemical vapor deposition (MOCVD), single wafer etch & clean and lithography technologies play an integral role in the fabrication and packaging of advanced semiconductor devices. With equipment designed to optimize performance, yield and cost of ownership, Veeco holds leading technology positions in the markets we serve. To learn more about Veeco’s systems and service offerings, visit www.veeco.com.

Forward-looking Statements

This press release contains “forward-looking statements”, within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, as amended, that are based on management’s expectations, estimates, projections and assumptions. Words such as “expects,” “anticipates,” “plans,” “believes,” “scheduled,” “estimates” and variations of these words and similar expressions are intended to identify forward-looking statements. Forward-looking statements include, but are not limited to, those regarding anticipated growth and trends in our businesses and markets, industry outlooks and demand drivers, our investment and growth strategies, our development of new products and technologies, our business outlook for current and future periods, our ongoing transformation initiative and the effects thereof on our operations and financial results; and other statements that are not historical facts. These statements and their underlying assumptions are subject to risks and uncertainties and are not guarantees of future performance. Factors that could cause actual results to differ materially from those expressed or implied by such statements include, without limitation: the level of demand for our products; global economic and industry conditions; global trade issues, including the ongoing trade disputes between the U.S. and China, and changes in trade and export license policies; our dependency on third-party suppliers and outsourcing partners; the timing of customer orders; our ability to develop, deliver and support new products and technologies; our ability to expand our current markets, increase market share and develop new markets; the concentrated nature of our customer base; our ability to obtain and protect intellectual property rights in key technologies; the effects of regional or global health epidemics; our ability to achieve the objectives of operational and strategic initiatives and attract, motivate and retain key employees; the variability of results among products and end-markets, and our ability to accurately forecast future results, market conditions, and customer requirements; the impact of our indebtedness, including our convertible senior notes and our capped call transactions; and other risks and uncertainties described in our SEC filings on Forms 10-K, 10-Q and 8-K, and from time-to-time in our other SEC reports. All forward-looking statements speak only to management’s expectations, estimates, projections and assumptions as of the date of this press release or, in the case of any document referenced herein or incorporated by reference, the date of that document. The Company does not undertake any obligation to update or publicly revise any forward-looking statements to reflect events, circumstances or changes in expectations after the date of this press release.

–financial tables attached-


Veeco Contacts:

Investors:	Anthony Pappone	(516) 500-8798	[email protected]
Media:	Brenden Wright	(410) 984-2610	[email protected]


Veeco Instruments Inc. and Subsidiaries Condensed Consolidated Statements of Operations (in thousands, except per share amounts) (unaudited)

	Three months ended December 31,						Year ended December 31,
	2024			2023			2024			2023
Net sales	$	182,131		$	173,924		$	717,301		$	666,435
Cost of sales		108,146			95,269			413,296			381,376
Gross profit		73,985			78,655			304,005			285,059
Operating expenses, net:
Research and development		30,953			29,091			124,507			112,853
Selling, general, and administrative		25,077			23,493			99,663			92,756
Amortization of intangible assets		1,580			2,123			6,983			8,481
Asset impairment		28,131			—			28,131			—
Other operating expense (income), net		(15,635	)		(235	)		(22,260	)		1,029
Total operating expenses, net		70,106			54,472			237,024			215,119
Operating income		3,879			24,183			66,981			69,940
Interest income (expense), net		476			—			1,853			(1,187	)
Other income (expense), net		—			—			—			(97,091	)
Income (loss) before income taxes		4,355			24,183			68,834			(28,338	)
Income tax expense (benefit)		(10,610	)		2,546			(4,880	)		2,030
Net income (loss)	$	14,965		$	21,637		$	73,714		$	(30,368	)

Income (loss) per common share:
Basic	$	0.26		$	0.39		$	1.31		$	(0.56	)
Diluted	$	0.26		$	0.37		$	1.23		$	(0.56	)

Weighted average number of shares:
Basic		56,536			55,537			56,426			53,769
Diluted		60,499			59,821			61,596			53,769


Veeco Instruments Inc. and Subsidiaries Condensed Consolidated Balance Sheets (in thousands)

	December 31,		December 31,
	2024		2023
	(unaudited)
Assets
Current assets:
Cash and cash equivalents	$	145,595	$	158,781
Restricted cash		224		339
Short-term investments		198,719		146,664
Accounts receivable, net		96,834		103,018
Contract assets		37,109		24,370
Inventories		246,735		237,635
Prepaid expenses and other current assets		39,316		35,471
Total current assets		764,532		706,278
Property, plant and equipment, net		113,789		118,459
Operating lease right-of-use assets		26,503		24,377
Intangible assets, net		8,832		43,945
Goodwill		214,964		214,964
Deferred income taxes		120,191		117,901
Other assets		2,766		3,117
Total assets	$	1,251,577	$	1,229,041

Liabilities and stockholders’ equity
Current liabilities:
Accounts payable	$	43,519	$	42,383
Accrued expenses and other current liabilities		55,195		57,624
Contract liabilities		64,986		118,026
Income taxes payable		2,086		—
Current portion of long-term debt		26,496		—
Total current liabilities		192,282		218,033
Deferred income taxes		689		6,552
Long-term debt		249,702		274,941
Long-term operating lease liabilities		34,318		31,529
Other liabilities		3,816		25,544
Total liabilities		480,807		556,599

Total stockholders’ equity		770,770		672,442
Total liabilities and stockholders’ equity	$	1,251,577	$	1,229,041

Note on Reconciliation Tables

The below tables include financial measures adjusted for the impact of certain items; these financial measures are therefore not calculated in accordance with U.S. generally accepted accounting principles (“GAAP”). These Non-GAAP financial measures exclude items such as: share-based compensation expense; charges relating to restructuring initiatives; non-cash asset impairments; certain other non-operating gains and losses; and acquisition-related items such as transaction costs, non-cash amortization of acquired intangible assets, and certain integration costs.

These Non-GAAP financial measures may be different from Non-GAAP financial measures used by other companies. Non-GAAP financial measures should not be considered a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP. By excluding these items, Non-GAAP financial measures are intended to facilitate meaningful comparisons to historical operating results, competitors’ operating results, and estimates made by securities analysts. Management is evaluated on key performance metrics including Non-GAAP Operating income (loss), which is used to determine management incentive compensation as well as to forecast future periods. These Non-GAAP financial measures may be useful to investors in allowing for greater transparency of supplemental information used by management in its financial and operational decision-making. In addition, similar Non-GAAP financial measures have historically been reported to investors; the inclusion of comparable numbers provides consistency in financial reporting. Investors are encouraged to review the reconciliation of the Non-GAAP financial measures used in this news release to their most directly comparable GAAP financial measures.


Reconciliation of GAAP to Non-GAAP Financial Data (Q4 2024) (in thousands) (unaudited)

				Non-GAAP Adjustments
				Share-Based
Three months ended December 31, 2024	GAAP			Compensation		Amortization		Other			Non-GAAP
Net sales	$	182,131									$	182,131
Gross profit		73,985		1,523								75,508
Gross margin		40.6	%									41.5	%
Operating expenses		70,106		(7,582	)	(1,580	)	(12,876	)			48,068
Operating income		3,879		9,105		1,580		12,876		^		27,440
Net income		14,965		9,105		1,580		(1,443	)	^		24,207

____________________________
^ – See table below for additional details.


Other Non-GAAP Adjustments (Q4 2024) (in thousands) (unaudited)

Three months ended December 31, 2024
Asset impairment	$	28,131
Changes in contingent consideration		(16,466	)
Other		1,211
Subtotal		12,876
Non-cash interest expense		322
Tax benefits associated with asset impairments		(12,239	)
Non-GAAP tax adjustment *		(2,402	)
Total Other	$	(1,443	)

____________________________
* – The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.


Net Income per Common Share (Q4 2024) (in thousands, except per share amounts) (unaudited)

	Three months ended December 31, 2024
	GAAP		Non-GAAP
Numerator:
Net income	$	14,965	$	24,207
Interest expense associated with 2025 and 2027 Convertible Senior Notes		513		466
Net income available to common shareholders	$	15,478	$	24,673

Denominator:
Basic weighted average shares outstanding		56,536		56,536
Effect of potentially dilutive share-based awards		1,070		1,070
Dilutive effect of 2025 Convertible Senior Notes		1,104		1,104
Dilutive effect of 2027 Convertible Senior Notes⁽¹⁾		1,789		1,354
Diluted weighted average shares outstanding		60,499		60,064

Net income per common share:
Basic	$	0.26	$	0.43
Diluted	$	0.26	$	0.41

____________________________
⁽¹⁾ – The non-GAAP incremental dilutive shares includes the impact of the Company’s capped call transaction issued concurrently with our 2027 Notes, and as such, an effective conversion price of $18.46 is used when determining incremental shares to add to the dilutive share count. The GAAP incremental dilutive shares does not include the impact of the Company’s capped call transaction, and as such, an effective conversion price of $13.98 is used when determining incremental shares to add to the dilutive share count.


Reconciliation of GAAP to Non-GAAP Financial Data (Q4 2023) (in thousands) (unaudited)

				Non-GAAP Adjustments
				Share-based
Three months ended December 31, 2023		GAAP		Compensation		Amortization		Other			Non-GAAP
Net sales	$	173,924									$	173,924
Gross profit		78,655		334								78,989
Gross margin		45.2	%									45.4	%
Operating expenses		54,472		(5,845	)	(2,123	)	363				46,867
Operating income		24,183		6,179		2,123		(363	)	^		32,122
Net income		21,637		6,179		2,123		(116	)	^		29,823

____________________________
^ – See table below for additional details.


Other Non-GAAP Adjustments (Q4 2023) (in thousands) (unaudited)

Three months ended December 31, 2023
Changes in contingent consideration	$	(465	)
Other		102
Subtotal		(363	)
Non-cash interest expense		294
Non-GAAP tax adjustment *		(47	)
Total Other	$	(116	)

____________________________
* – The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.


Net Income per Common Share (Q4 2023) (in thousands, except per share amounts) (unaudited)

	Three months ended December 31, 2023
	GAAP		Non-GAAP
Numerator:
Net income	$	21,637	$	29,823
Interest expense associated with 2025 and 2027 Convertible Senior Notes		511		466
Net income available to common shareholders	$	22,148	$	30,289

Denominator:
Basic weighted average shares outstanding		55,537		55,537
Effect of potentially dilutive share-based awards		1,391		1,391
Dilutive effect of 2025 Convertible Senior Notes		1,104		1,104
Dilutive effect of 2027 Convertible Senior Notes⁽¹⁾		1,789		1,355
Diluted weighted average shares outstanding		59,821		59,387

Net income per common share:
Basic	$	0.39	$	0.54
Diluted	$	0.37	$	0.51

____________________________
(1) – The non-GAAP incremental dilutive shares includes the impact of the Company’s capped call transaction issued concurrently with our 2027 Notes, and as such, an effective conversion price of $18.46 is used when determining incremental shares to add to the dilutive share count. The GAAP incremental dilutive shares does not include the impact of the Company’s capped call transaction, and as such, an effective conversion price of $13.98 is used when determining incremental shares to add to the dilutive share count.


Reconciliation of GAAP Net Income to Non-GAAP Operating Income (Q4 2024 and 2023) (in thousands) (unaudited)

	Three months ended			Three months ended
	December 31, 2024			December 31, 2023
GAAP Net income	$	14,965		$	21,637
Share-based compensation		9,105			6,179
Amortization		1,580			2,123
Asset impairment		28,131			—
Changes in contingent consideration		(16,466	)		(465	)
Transition expenses related to San Jose expansion project		—			57
Acquisition related		—			45
Interest (income) expense, net		(476	)		—
Other		1,211			—
Income tax expense (benefit)		(10,610	)		2,546
Non-GAAP Operating income	$	27,440		$	32,122


Reconciliation of GAAP to Non-GAAP Financial Data (FY 2024) (in thousands) (unaudited)

				Non-GAAP Adjustments
				Share-based
For the year ended December 31, 2024		GAAP		Compensation		Amortization		Other			Non-GAAP
Net sales	$	717,301									$	717,301
Gross profit		304,005		6,263				162				310,430
Gross margin		42.4	%									43.3	%
Operating expenses		237,024		(29,616	)	(6,983	)	(6,067	)			194,358
Operating income		66,981		35,879		6,983		6,229		^		116,072
Net income (loss)		73,714		35,879		6,983		(12,233	)	^		104,343

____________________________
^ – See table below for additional details.


Other Non-GAAP Adjustments (FY 2024) (in thousands) (unaudited)

For the year ended December 31, 2024
Asset impairment	$	28,131
Changes in contingent consideration		(21,242	)
Sale of productive assets		(2,033	)
Other		1,373
Subtotal		6,229
Non-cash interest expense		1,257
Tax benefits associated with asset impairments		(12,239	)
Non-GAAP tax adjustment *		(7,480	)
Total Other	$	(12,233	)

____________________________
* – The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.


Net Income per Common Share (FY 2024) (in thousands, except per share amounts) (unaudited)

	Year ended December 31, 2024
	GAAP		Non-GAAP
Numerator:
Net income	$	73,714	$	104,343
Interest expense associated with convertible notes		2,054		1,865
Net income available to common shareholders	$	75,768	$	106,208

Denominator:
Basic weighted average shares outstanding		56,426		56,426
Effect of potentially dilutive share-based awards		1,010		1,010
Dilutive effect of 2025 Convertible Senior Notes		1,104		1,104
Dilutive effect of 2027 Convertible Senior Notes⁽¹⁾		1,788		1,354
Dilutive effect of 2029 Convertible Senior Notes		1,268		1,268
Diluted weighted average shares outstanding		61,596		61,162

Net income per common share:
Basic	$	1.31	$	1.85
Diluted	$	1.23	$	1.74


Reconciliation of GAAP to Non-GAAP Financial Data (FY 2023) (in thousands) (unaudited)

					Non-GAAP Adjustments
					Share-based
For the year ended December 31, 2023		GAAP			Compensation		Amortization		Other			Non-GAAP
Net sales	$	666,435										$	666,435
Gross profit		285,059			4,913				232				290,204
Gross margin		42.8		%									43.5	%
Operating expenses		215,119			(23,645	)	(8,481	)	(2,363	)			180,630
Operating income		69,940			28,558		8,481		2,595		^		109,574
Net income (loss)		(30,368	)		28,558		8,481		91,668		^		98,339

____________________________
^ – See table below for additional details.


Other Non-GAAP Adjustments (FY 2023) (in thousands) (unaudited)

For the year ended December 31, 2023
Acquisition related	$	1,056
Changes in contingent consideration		701
Transition expenses related to San Jose expansion project		838
Subtotal		2,595
Non-cash interest expense		1,118
Other (income) expense, net		97,091
Non-GAAP tax adjustment *		(9,136	)
Total Other	$	91,668

____________________________
* – The ‘with or without’ method is utilized to determine the income tax effect of all Non-GAAP adjustments.


Net Income per Common Share (FY 2023) (in thousands, except per share amounts) (unaudited)

	Year ended December 31, 2023
	GAAP			Non-GAAP
Numerator:
Net income (loss)	$	(30,368	)	$	98,339
Interest expense associated with convertible notes		—			4,768
Net income (loss) available to common shareholders	$	(30,368	)	$	103,107

Denominator:
Basic weighted average shares outstanding		53,769			53,769
Effect of potentially dilutive share-based awards		—			850
Dilutive effect of 2023 Convertible Senior Notes		—			21
Dilutive effect of 2025 Convertible Senior Notes		—			2,786
Dilutive effect of 2027 Convertible Senior Notes⁽¹⁾		—			3,417
Diluted weighted average shares outstanding		53,769			60,843

Net income per common share:
Basic	$	(0.56	)	$	1.83
Diluted	$	(0.56	)	$	1.69


Reconciliation of GAAP Net Income to Non-GAAP Operating Income (FY 2024 and 2023) (in thousands) (unaudited)

	Year ended			Year ended
	December 31, 2024			December 31, 2023
GAAP Net income (loss)	$	73,714		$	(30,368	)
Share-based compensation		35,879			28,558
Amortization		6,983			8,481
Asset impairment		28,131			—
Acquisition related		—			1,056
Changes in contingent consideration		(21,242	)		701
Transition expenses related to San Jose expansion project		—			838
Sales of productive assets		(2,033	)		—
Interest (income) expense, net		(1,853	)		1,187
Other		1,373			97,091
Income tax expense (benefit)		(4,880	)		2,030
Non-GAAP Operating income (loss)	$	116,072		$	109,574


Reconciliation of GAAP to Non-GAAP Financial Data (Q1 2025) (in millions, except per share amounts) (unaudited)

								Non-GAAP Adjustments
Guidance for the three months ending								Share-based
March 31, 2025	GAAP							Compensation		Amortization		Other		Non-GAAP
Net sales	$	155		–	$	175								$	155		–	$	175
Gross profit		63		–		72		2		—		—			65		–		74
Gross margin		41	%	–		41	%								42	%	–		42	%
Operating expenses		56		–		58		(8	)	(1	)	—			47		–		49
Operating income		7		–		14		10		1		—			18		–		25
Net income	$	7		–	$	13		10		1		(2	)	$	16		–	$	22

Income per diluted common share	$	0.11		–	$	0.22								$	0.26		–	$	0.36


Income per Diluted Common Share (Q1 2025) (in millions, except per share amounts) (unaudited)

Guidance for the three months ending March 31, 2025	GAAP					Non-GAAP
Numerator:
Net income available to common shareholders	$	7	–	$	13	$	16	–	$	22

Denominator:
Basic weighted average shares outstanding		58			58		58			58
Effect of potentially dilutive share-based awards		1			1		1			1
Dilutive effect of 2027 Convertible Senior Notes⁽¹⁾		—			2		1			1
Diluted weighted average shares outstanding		59			61		60			60

Net income per common share:
Income per diluted common share	$	0.11	–	$	0.22	$	0.26	–	$	0.36


Reconciliation of GAAP Net Income to Non-GAAP Operating Income (Q1 2025) (in millions) (unaudited)

Guidance for the three months ending March 31, 2025
GAAP Net income	$	7	–	$	13
Share-based compensation		10	–		10
Amortization		1	–		1
Income tax expense		—	–		1
Non-GAAP Operating income	$	18	–	$	25

Note: Amounts may not calculate precisely due to rounding.